Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.06 |
D018352 | Coronavirus Infections NIH | 0.05 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This trial is designed to determine if the inflammation modulating effect of vagus nerve stimulation can improve pulmonary function and limit progression to ARDS in hospitalized COVID-19 hospitalized patients.
Description: Survival
Measure: Survival without need of mechanical ventilation Time: Day 14 since symptom onsetDescription: WHO Progression Scale
Measure: WHO progression scale ≤ 5 at day 4 since admission. Time: Score on day 4 since admissionDescription: Successful tracheal extubation
Measure: Cumulative incidence of successful tracheal extubation at day 14 since symptom onset. Time: Day 14 since symptom onsetDescription: WHO Progression Scale
Measure: WHO progression scale ≤ 7 at day 4 since admission. Time: Score on day 7 since admissionDescription: Survival
Measure: Survival at day 14 of hospitalization Time: Day 14Description: Duration of hospitalization
Measure: Duration of hospitalization Time: Day 28Description: Time to hospital discharge
Measure: Time to hospital discharge Time: Day 28